Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases.

Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases.

Item
http://www.wikidata.org/entity/Q33417756
Maximising the potential of AKT inhibitors as anti-cancer treatmentsCurrent role of autologous and allogeneic stem cell transplantation for relapsed and refractory hodgkin lymphoma.Primary refractory and early-relapsed Hodgkin's lymphoma: strategies for therapeutic targeting based on the tumour microenvironment.Integrated Akt/PKB signaling in immunomodulation and its potential role in cancer immunotherapy.Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphoma.Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.Innovation in non-Hodgkin lymphoma drug discovery: what needs to be done?Novel agents in classical Hodgkin lymphoma.SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1.
P2860

Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases.

Item
http://www.wikidata.org/entity/Q33417756
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Phase II study of perifosine a ...... lymphoproliferative diseases.
@ast
Phase II study of perifosine a ...... lymphoproliferative diseases.
@en
type
label
Phase II study of perifosine a ...... lymphoproliferative diseases.
@ast
Phase II study of perifosine a ...... lymphoproliferative diseases.
@en
prefLabel
Phase II study of perifosine a ...... lymphoproliferative diseases.
@ast
Phase II study of perifosine a ...... lymphoproliferative diseases.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Phase II study of perifosine a ...... lymphoproliferative diseases.
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-14-0770
P407
P433
P478
P50
P577
P698